Your browser doesn't support javascript.
loading
Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy.
Chen, Huanpeng; Yang, Yuying; Deng, Yuqing; Wei, Fengjiao; Zhao, Qingyu; Liu, Yongqi; Liu, Zhonghua; Yu, Bolan; Huang, Zhaofeng.
Afiliación
  • Chen H; BioResource Research Center, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Yang Y; Institute of Human Virology, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China.
  • Deng Y; Institute of Human Virology, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China.
  • Wei F; Key Laboratory of Tropical Disease Control, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Zhao Q; Faculty of Science, Monash University, Clayton, Victoria, Australia.
  • Liu Y; Institute of Human Virology, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, Guangdong, China.
  • Liu Z; Key Laboratory of Tropical Disease Control, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Yu B; ICU, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
  • Huang Z; Laboratory Animal Center, South China Agricultural University, Guangzhou, Guangdong, China.
J Immunother Cancer ; 10(2)2022 02.
Article en En | MEDLINE | ID: mdl-35110357
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Inmunológicos / Antígeno CD47 / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Inmunológicos / Antígeno CD47 / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido